Human 3D lung cancer tissue photothermal therapy using Zn- and Co-doped magnetite nanoparticles
Carregando...
Data
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Iron oxide-based nanoparticles are promising materi als for cancer thermal therapy and immunotherapy. However, several
proofs of concept reported data with murine tumor models that
might have limitations for clinical translation. Magnetite is nowadays
the most popular nanomaterial, but doping with distinct ions can
enhance thermal therapy, namely, magnetic nanoparticle hyper thermia (MNH) and photothermal therapy (PTT). In this study, we
used a 3D alveolar reconstructed A549 lung cancer tissue model and
investigated the thermal properties, toxicity, and impact of the
thermal dose on tissue viability and inflammatory response using
magnetite codoped with 40% Zn and 2% Co divalent ions. The
ZnCo-doped magnetite nanoparticles are not toxic up to an NP
concentration of 30 mg/mL. PTT showed a better heat generation
response than MNH under the evaluated conditions, while NP showed a high external photothermal conversion efficiency of ∼1.3 g· L−1·cm−1 at 808 nm. PTT study is carried out at different temperatures, 43 and 47 °C, for 15 min. Tissue viability decreased with
increasing thermal dose, while intracelullar ROS levels increased, mitochondrial activity decreased, and active caspase-3 increased,
suggesting cell death via apoptosis. Nanoparticles and PTT did not influence the cytokine TNF, IL-10, IL-1B, and IL-12p70. In
contrast, IL-6 and IL-8 were triggered by NP and PTT. Increased expression of IL-6 and IL-8 with higher thermal doses is correlated
with tissue injury results, suggesting the potential role in activating and attracting immune cells to the site of thermal-mediated tissue
injury.
Descrição
Palavras-chave
Citação
MORAES, Edynara Cruz de et al. Human 3D lung cancer tissue photothermal therapy using Zn- and Co-doped magnetite nanoparticles. ACS Biomaterials Science & Engineering, Washington, v. 11, n. 2, p. 1084-1095, 2025. DOI: 10.1021/acsbiomaterials.4c01901. Disponível em: https://pubs.acs.org/doi/10.1021/acsbiomaterials.4c01901. Acesso em: 20 ago. 2025.